DUSA Pharmaceuticals, Inc.

Industry

  • Biotechnology
See more in Biomedtracker

Latest on DUSA Pharmaceuticals, Inc.

Medtech Insight

Attorneys Predict Pandemic-Related Rise In False Claims Allegations

 
• By Elizabeth Orr

Don’t mistake a recent drop in False Claims Act (FCA) recoveries for lack of interest in pursuing medtech companies who flout the law, a group of attorneys cautioned at a 10 December conference hosted

Scrip

M&A Trends: The Growing Indian Appetite

 
• By Anju Ghangurde

A recent discussion in Mumbai on trends in the pharmaceutical and healthcare sector especially from the mergers and acquisitions (M&A) and funding perspective highlighted the appetite of large Indian

HBW Insight

Sun Pharma’s $4B Ranbaxy Buy Brings Consumer Products Business With New Growth Focus

 
• By Jessica Merrill and Vikas Dandekar

AstraZeneca PLC could come out the big winner if Sun Pharmaceutical Industries Ltd. ’s proposed takeover of Ranbaxy Laboratories Ltd. impacts the launch timeline for generic versions of the b

Pink Sheet

Sun Pharma’s $4B Ranbaxy Buy Brings Consumer Products Business With New Growth Focus

 
• By Jessica Merrill and Vikas Dandekar

AstraZeneca PLC could come out the big winner if Sun Pharmaceutical Industries Ltd. ’s proposed takeover of Ranbaxy Laboratories Ltd. impacts the launch timeline for generic versions of the b